Applying mathematical modelling to estimate the impact of COVID-19-related VMMC service disruptions on new HIV infections in Zimbabwe.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
23 Feb 2023
Historique:
received: 29 06 2022
accepted: 13 02 2023
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

The COVID-19 pandemic has overwhelmed health systems with knock on effects on diagnosis, treatment, and care. To mitigate the impact, the government of Zimbabwe enforced a strict lockdown beginning 30 March 2020 which ran intermittently until early 2021. In this period, the Ministry of Health and Childcare strategically prioritized delivery of services leading to partial and full suspension of services considered non-essential, including HIV prevention. As a result, Voluntary Medical Male Circumcision (VMMC) services were disrupted leading to an 80% decline in circumcisions conducted in 2020. Given the efficacy of VMMC, we quantified the potential effects of VMMC service disruption on new HIV infections in Zimbabwe. We applied the GOALS model to evaluate the impact of COVID-19-related disruptions on reducing new HIV infections over 30-years. GOALS is an HIV simulation model that estimates number of new HIV infections based on sexual behaviours of population groups. The model is parameterized based on national surveys and HIV program data. We hypothesized three coverage scenarios by 2030: scenario I - pre-COVID trajectory: 80% VMMC coverage; Scenario II - marginal COVID-19 impact: 60% VMMC coverage, and scenario III - severe COVID-19 impact: 45% VMMC coverage. VMMC coverage between 2020 and 2030 was linearly interpolated to attain the estimated coverage and then held constant from 2030 to 2050, and discounted outcomes at 3%. Compared to the baseline scenario I, in scenario II, we estimated that the disruption of VMMC services would generate an average of 200 (176-224) additional new infections per year and 7,200 new HIV infections over the next 30 years. For scenario III, we estimated an average of 413 (389-437) additional new HIV infections per year and 15,000 new HIV infections over the next 30 years. The disruption of VMMC services could generate additional future HIV treatment costs ranging from $27 million to $55 million dollars across scenarios II and III, respectively. COVID-19 disruptions destabilized delivery of VMMC services which could contribute to an additional 7,200 new infections over the next 30 years. Unless mitigated, these disruptions could derail the national goals of reducing new infections by 2030.

Sections du résumé

BACKGROUND BACKGROUND
The COVID-19 pandemic has overwhelmed health systems with knock on effects on diagnosis, treatment, and care. To mitigate the impact, the government of Zimbabwe enforced a strict lockdown beginning 30 March 2020 which ran intermittently until early 2021. In this period, the Ministry of Health and Childcare strategically prioritized delivery of services leading to partial and full suspension of services considered non-essential, including HIV prevention. As a result, Voluntary Medical Male Circumcision (VMMC) services were disrupted leading to an 80% decline in circumcisions conducted in 2020. Given the efficacy of VMMC, we quantified the potential effects of VMMC service disruption on new HIV infections in Zimbabwe.
METHODS METHODS
We applied the GOALS model to evaluate the impact of COVID-19-related disruptions on reducing new HIV infections over 30-years. GOALS is an HIV simulation model that estimates number of new HIV infections based on sexual behaviours of population groups. The model is parameterized based on national surveys and HIV program data. We hypothesized three coverage scenarios by 2030: scenario I - pre-COVID trajectory: 80% VMMC coverage; Scenario II - marginal COVID-19 impact: 60% VMMC coverage, and scenario III - severe COVID-19 impact: 45% VMMC coverage. VMMC coverage between 2020 and 2030 was linearly interpolated to attain the estimated coverage and then held constant from 2030 to 2050, and discounted outcomes at 3%.
RESULTS RESULTS
Compared to the baseline scenario I, in scenario II, we estimated that the disruption of VMMC services would generate an average of 200 (176-224) additional new infections per year and 7,200 new HIV infections over the next 30 years. For scenario III, we estimated an average of 413 (389-437) additional new HIV infections per year and 15,000 new HIV infections over the next 30 years. The disruption of VMMC services could generate additional future HIV treatment costs ranging from $27 million to $55 million dollars across scenarios II and III, respectively.
CONCLUSION CONCLUSIONS
COVID-19 disruptions destabilized delivery of VMMC services which could contribute to an additional 7,200 new infections over the next 30 years. Unless mitigated, these disruptions could derail the national goals of reducing new infections by 2030.

Identifiants

pubmed: 36823550
doi: 10.1186/s12879-023-08081-7
pii: 10.1186/s12879-023-08081-7
pmc: PMC9948776
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113

Informations de copyright

© 2023. The Author(s).

Références

Health Policy Plan. 2020 Feb 1;35(1):107-114
pubmed: 31625564
BMJ Open. 2021 Mar 10;11(3):e042934
pubmed: 33692179
Lancet. 2008 Aug 16;372(9638):585-99
pubmed: 18687456
PLoS Med. 2011 Nov;8(11):e1001132
pubmed: 22140367
Lancet. 2007 Feb 24;369(9562):643-56
pubmed: 17321310
AIDS. 2021 Feb 2;35(2):299-306
pubmed: 33170578
PLoS Med. 2021 Oct 18;18(10):e1003831
pubmed: 34662333
Lancet HIV. 2020 Sep;7(9):e629-e640
pubmed: 32771089

Auteurs

Newton Chagoma (N)

Clinton Health Access Initiative, Boston, USA.

Tiwonge Kanyenda (T)

Clinton Health Access Initiative, Boston, USA.

Bothwell Pindiwe (B)

Clinton Health Access Initiative, Harare, Zimbabwe.

Howard Nyika (H)

Ministry of Health and Child Care, Harare, Zimbabwe.

Lawrence Nyazema (L)

Ministry of Health and Child Care, Harare, Zimbabwe.

John Stover (J)

Avenir Health, Glastonbury, USA.

Danielle Resar (D)

Clinton Health Access Initiative, Boston, USA.

Natsai Shoko (N)

Clinton Health Access Initiative, Boston, USA.

Sarah Jenkins (S)

Clinton Health Access Initiative, Boston, USA.

Yemurai Katanda (Y)

Clinton Health Access Initiative, Boston, USA. ykatanda@clintonhealthaccess.org.

Sinokuthemba Xaba (S)

Ministry of Health and Child Care, Harare, Zimbabwe.

Owen Mugurungi (O)

Ministry of Health and Child Care, Harare, Zimbabwe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH